|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.495 SEK | -1.64% |
|
+0.34% | +64.65% |
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Revenues | 41.62L | 58.54L | 1.6Cr | 1.64Cr | 1.36Cr |
Total Revenues | 41.62L | 58.54L | 1.6Cr | 1.64Cr | 1.36Cr |
Cost of Goods Sold, Total | 53.45L | 99.8L | 1.73Cr | 2.47Cr | 2.35Cr |
Gross Profit | -11.83L | -41.26L | -12.96L | -82.98L | -99.04L |
Selling General & Admin Expenses, Total | 11.54L | 17.4L | - | - | - |
Depreciation & Amortization - (IS) | 50.01T | 50T | 25T | 1L | 2L |
Other Operating Expenses | -3.01T | 6T | 11T | -20T | -1T |
Other Operating Expenses, Total | 12.01L | 17.96L | 36T | 1L | 2L |
Operating Income | -23.84L | -59.22L | -13.32L | -84.13L | -1.01Cr |
Interest Expense, Total | -88 | -1L | -1T | -5T | -3L |
Interest And Investment Income | 1.18T | - | - | - | - |
Net Interest Expenses | -88 | -1L | -1T | -5T | -3L |
Other Non Operating Income (Expenses) | 2 | - | - | - | 1T |
EBT, Excl. Unusual Items | -23.84L | -60.25L | -13.33L | -84.18L | -1.04Cr |
EBT, Incl. Unusual Items | -23.84L | -60.25L | -13.33L | -84.18L | -1.04Cr |
Earnings From Continuing Operations | -23.84L | -60.25L | -13.33L | -84.18L | -1.04Cr |
Net Income to Company | -23.84L | -60.25L | -13.33L | -84.18L | -1.04Cr |
Net Income - (IS) | -23.84L | -60.25L | -13.33L | -84.18L | -1.04Cr |
Net Income to Common Incl Extra Items | -23.84L | -60.25L | -13.33L | -84.18L | -1.04Cr |
Net Income to Common Excl. Extra Items | -23.84L | -60.25L | -13.33L | -84.18L | -1.04Cr |
Per Share Items | |||||
Net EPS - Basic | - | -0.39 | -0.07 | -0.34 | -0.2 |
Basic EPS - Continuing Operations | - | -0.39 | -0.07 | -0.34 | -0.2 |
Net EPS - Diluted | - | -0.39 | -0.07 | -0.34 | -0.2 |
Diluted EPS - Continuing Operations | - | -0.39 | -0.07 | -0.34 | -0.2 |
Normalized Basic EPS | - | -0.24 | -0.04 | -0.21 | -0.13 |
Normalized Diluted EPS | - | -0.24 | -0.04 | -0.21 | -0.13 |
Supplemental Items | |||||
EBITDA | -15.07L | -58.72L | -13.07L | -82.78L | -99.03L |
EBITA | -23.84L | -59.22L | -13.32L | -84.13L | -1.01Cr |
EBIT | -23.84L | -59.22L | -13.32L | -84.13L | -1.01Cr |
Total Revenues (As Reported) | 41.68L | 58.73L | 1.6Cr | 1.65Cr | 1.36Cr |
Normalized Net Income | -14.9L | -37.66L | -8L | -52.61L | -64.88L |
Supplemental Operating Expense Items | |||||
Research And Development Expense From Footnotes | 50.01T | 50T | 25T | 1L | 3L |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















